PFE Pfizer Inc
Health Care > Pharmaceuticals, Biotechnology & Life Sciences > Pharmaceuticals > Pharmaceuticals | NYSE, MostTraded, LargeCap | Last Price: 27.65 | 2026-02-27 | Atrp: 2.06
Sat 21 Feb 2026 to Fri 27 Feb 2026: Score -3
| Metric | Previous | New | Change | Interpretation | |
|---|---|---|---|---|---|
| â | PEG Ratio | 3.7725 | 13.7734 | ▲ 265.1% | Bearish. Lower is better. Extreme increase, worsening the value relative to growth P/E ratio adjusted for growth rate |
| â | Price Sales TTM | 2.4213 | 2.4622 | ▲ 1.69% | Bearish. Lower is better. Higher multiple; market willing to pay more per dollar of sales Stock price divided by revenue per share over the trailing twelve months |
| â | Enterprise Value | $202.68B | $199.95B | ▼ -1.35% | Bearish. Higher is better. Decreased, reflecting lower market cap and possibly debt adjustments Market capitalization plus debt minus cash |
| â | Short Percent | 2.52% | 2.58% | ▲ 2.38% | Bearish. Lower is better. Slight increase; still high, potential for squeeze if positive catalysts emerge Percentage of shares sold short |
| â | Price Book MRQ | 1.6898 | 1.6604 | ▼ -1.74% | Bullish. Lower is better. Closer to 1; less overvalued on assets but improved perception Stock price divided by book value per share for the most recent quarter |
| â | Enterprise Value/Revenue | 3.2387 | 3.1951 | ▼ -1.35% | Bullish. Lower is better. Slight improvement Enterprise value divided by revenue |
| â | Enterprise Value/EBITDA | 13.4534 | 13.2723 | ▼ -1.35% | Bullish. Lower is better. Slight improvement Enterprise value to earnings before interest, taxes, depreciation |
| â | Short Ratio | 3 | 2.69 | ▼ -10.33% | Bullish. Lower is better. Moderate improvement |
Sat 14 Feb 2026 to Sat 21 Feb 2026: Score 1
| Metric | Previous | New | Change | Interpretation | |
|---|---|---|---|---|---|
| â | Price Sales TTM | 2.5058 | 2.4213 | ▼ -3.37% | Bullish. Lower is better. Lower multiple; market willing to pay less per dollar of sales Stock price divided by revenue per share over the trailing twelve months |
Sat 07 Feb 2026 to Sat 14 Feb 2026: Score -9
| Metric | Previous | New | Change | Interpretation | |
|---|---|---|---|---|---|
| â | Short Ratio | 2.7 | 3 | ▲ 11.11% | Bearish. Lower is better. Moderate decline |
| â | Short Percent | 2.28% | 2.52% | ▲ 10.53% | Bearish. Lower is better. Moderate increase; still high, potential for squeeze if positive catalysts emerge Percentage of shares sold short |
| â | Price Sales TTM | 2.4731 | 2.5058 | ▲ 1.32% | Bearish. Lower is better. Higher multiple; market willing to pay more per dollar of sales Stock price divided by revenue per share over the trailing twelve months |
| â | Price Book MRQ | 1.6408 | 1.683 | ▲ 2.57% | Bearish. Lower is better. Further to 1; more overvalued on assets but worsened perception Stock price divided by book value per share for the most recent quarter |
| â | Enterprise Value/Revenue | 3.166 | 3.2287 | ▲ 1.98% | Bearish. Lower is better. Slight decline Enterprise value divided by revenue |
| â | Enterprise Value/EBITDA | 13.1515 | 13.4119 | ▲ 1.98% | Bearish. Lower is better. Slight decline Enterprise value to earnings before interest, taxes, depreciation |
| â | Enterprise Value | $198.13B | $202.05B | ▲ 1.98% | Bullish. Higher is better. Increased, reflecting higher market cap and possibly debt adjustments Market capitalization plus debt minus cash |
Sat 31 Jan 2026 to Sat 07 Feb 2026: Score -13
| Metric | Previous | New | Change | Interpretation | |
|---|---|---|---|---|---|
| â | Operating Margin TTM | 35.28% | 24.63% | ▼ -30.19% | Bearish. Higher is better. Operating margin TTM growth slowing. Percentage of revenue left after operating expenses |
| â | Enterprise Value/EBITDA | 10.0055 | 13.1515 | ▲ 31.44% | Bearish. Lower is better. Significant decline Enterprise value to earnings before interest, taxes, depreciation |
| â | Earnings Per Share | 1.74 | 1.36 | ▼ -21.84% | Bearish. Higher is better. Significant decline in earnings per share Profit allocated to each outstanding share |
| â | Profit Margin | 15.65% | 12.42% | ▼ -20.64% | Bearish. Higher is better. Profit margin growth slowing. Percentage of revenue that turns into profit |
| â | Return On Equity TTM | 10.6% | 8.58% | ▼ -19.06% | Bearish. Higher is better. Return on equity TTM growth slowing. Efficiency in generating profits from shareholders' equity |
| â | EPS Estimate Current Year | 3.1237 | 2.9811 | ▼ -4.57% | Bearish. Higher is better. Slight decrease; reduced outlook for current year earnings Expected earnings per share this year |
| â | EPS Estimate Next Year | 2.9715 | 2.848 | ▼ -4.16% | Bearish. Higher is better. Slight lowered expectations for further out Expected earnings per share next year |
| â | Forward PE | 8.673 | 9.2336 | ▲ 6.46% | Bearish. Lower is better. Slight decline Stock price divided by expected future earnings |
| â | Price Sales TTM | 2.3944 | 2.4731 | ▲ 3.29% | Bearish. Lower is better. Higher multiple; market willing to pay more per dollar of sales Stock price divided by revenue per share over the trailing twelve months |
| â | Gross Profit TTM | $46968M | $47439M | ▲ 1% | Bullish. Higher is better. Slight increase, but margins may be improving Revenue minus cost of goods sold over the trailing twelve months |
| â | Enterprise Value | $194.26B | $198.13B | ▲ 1.99% | Bullish. Higher is better. Increased, reflecting higher market cap and possibly debt adjustments Market capitalization plus debt minus cash |
| â | EBITDA | $24459M | $25688.33M | ▲ 5.03% | Bullish. Higher is better. Increase in earnings before interest, taxes, depreciation, and amortization; indicates stronger operational cash flow Earnings before interest, taxes, depreciation, and amortization |
| â | Price Book MRQ | 1.7359 | 1.6408 | ▼ -5.48% | Bullish. Lower is better. Closer to 1; less overvalued on assets but improved perception Stock price divided by book value per share for the most recent quarter |
| â | Quarterly Revenue Growth YOY | -61% | -11% | ▲ 79.66% | Bullish. Higher is better. Quarterly revenue growth YOY decline slowing; potential stabilization. Year-over-year growth in quarterly revenue |
Sat 17 Jan 2026 to Sat 24 Jan 2026: Score -1
| Metric | Previous | New | Change | Interpretation | |
|---|---|---|---|---|---|
| â | Forward PE | 8.6655 | 8.8417 | ▲ 2.03% | Bearish. Lower is better. Slight decline Stock price divided by expected future earnings |
Sat 10 Jan 2026 to Sat 17 Jan 2026: Score -1
| Metric | Previous | New | Change | Interpretation | |
|---|---|---|---|---|---|
| â | Forward PE | 8.547 | 8.6655 | ▲ 1.39% | Bearish. Lower is better. Slight decline Stock price divided by expected future earnings |
| â | Price Book MRQ | 1.5495 | 1.5715 | ▲ 1.42% | Bearish. Lower is better. Further to 1; more overvalued on assets but worsened perception Stock price divided by book value per share for the most recent quarter |
| â | Enterprise Value/Revenue | 3.0207 | 3.0533 | ▲ 1.08% | Bearish. Lower is better. Slight decline Enterprise value divided by revenue |
| â | Enterprise Value/EBITDA | 10.2257 | 10.336 | ▲ 1.08% | Bearish. Lower is better. Slight decline Enterprise value to earnings before interest, taxes, depreciation |
| â | Enterprise Value | $189.66B | $191.7B | ▲ 1.08% | Bullish. Higher is better. Increased, reflecting higher market cap and possibly debt adjustments Market capitalization plus debt minus cash |
| â | Short Percent | 2.45% | 2.29% | ▼ -6.53% | Bullish. Lower is better. Slight decrease; still high, potential for squeeze if positive catalysts emerge Percentage of shares sold short |
Sat 03 Jan 2026 to Sat 10 Jan 2026: Score -4
| Metric | Previous | New | Change | Interpretation | |
|---|---|---|---|---|---|
| â | Forward PE | 8.4104 | 8.547 | ▲ 1.62% | Bearish. Lower is better. Slight decline Stock price divided by expected future earnings |
| â | Price Sales TTM | 2.2803 | 2.3074 | ▲ 1.19% | Bearish. Lower is better. Higher multiple; market willing to pay more per dollar of sales Stock price divided by revenue per share over the trailing twelve months |
| â | Price Book MRQ | 1.5256 | 1.5495 | ▲ 1.57% | Bearish. Lower is better. Further to 1; more overvalued on assets but worsened perception Stock price divided by book value per share for the most recent quarter |
| â | Enterprise Value/Revenue | 2.9853 | 3.0207 | ▲ 1.19% | Bearish. Lower is better. Slight decline Enterprise value divided by revenue |
| â | Enterprise Value/EBITDA | 10.1061 | 10.2257 | ▲ 1.18% | Bearish. Lower is better. Slight decline Enterprise value to earnings before interest, taxes, depreciation |
| â | Enterprise Value | $187.44B | $189.66B | ▲ 1.18% | Bullish. Higher is better. Increased, reflecting higher market cap and possibly debt adjustments Market capitalization plus debt minus cash |
Sun 21 Dec 2025 to Sat 03 Jan 2026: Score -5
| Metric | Previous | New | Change | Interpretation | |
|---|---|---|---|---|---|
| â | Short Ratio | 1.48 | 2.75 | ▲ 85.81% | Bearish. Lower is better. Substantial decline |
| â | Forward PE | 8.3126 | 8.4104 | ▲ 1.18% | Bearish. Lower is better. Slight decline Stock price divided by expected future earnings |
| â | Price Book MRQ | 1.5433 | 1.5256 | ▼ -1.15% | Bullish. Lower is better. Closer to 1; less overvalued on assets but improved perception Stock price divided by book value per share for the most recent quarter |